Our in-house medical, regulatory and operational experts work collaboratively to support your Phase IIb-III clinical trials as many moving parts go into Phase II and III clinical trials.
Our teams help eliminate delays by leading the way from recruitment strategies, medical writing, and clinical logistics, all the way through the regulatory process.
We combine scientific leadership with disciplined execution, global access to patients, and local and global regulatory expertise to accelerate your compound to approval.

Our Comprehensive Services for Accelerating Clinical Research

• Our expert physicians team provide strategic direction for study design, train operations staff, provide medical monitoring, work with primary investigators.
• Strategic regulatory leadership guides trial design and execution recommendations and meet with regulatory agencies.
• Dedicated global regulatory submissions teams experienced in key therapeutic and specialty area trial application processes and site start-up.
• Proprietary, integrated clinical study management technology platform facilitates efficient execution of global trials.
• Experienced in Data Safety Monitoring Committee management.
• Provides ongoing statistical support.
• Detailed site selection processes, ongoing tracking and site communication to maintain trial timelines.
• Extensive and rigorous in-house training program.